Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MISOPROSTOL FOR THE TREATMENT OF SUSPECTED POSTPARTUM RETAINED PRODUCTS OF CONCEPTION - A RANDOMIZED TRIAL

NCT06009679 is registered in ClinicalTrials.gov with Assuta Ashdod Hospital as lead sponsor.

NCT NCT06009679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06009679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MISOPROSTOL FOR THE TREATMENT OF SUSPECTED POSTPARTUM RETAINED PRODUCTS OF CONCEPTION - A RANDOMIZED TRIAL
Lead sponsor
Assuta Ashdod Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
February 2, 2021
Completion date
June 30, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retained products of conception